Cytomegalovirus Viraemia

1

Review clinical trials related to Cytomegalovirus Viraemia. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Individualised Dose Optimisation of Ganciclovir in Immunocompromised Children Trial (ID-MAGIC)

This study is being conducted at seven major children's hospitals in Australia and New Zealand to test a new approach for treating a virus, called cytomegalovirus in children with weakened immune systems. The researchers want to find out if using a web app to customise the dose of a medication called ganciclovir is better at clearing the virus over a six-week period compared to the standard method of giving the medication.

Participants needed: 232
Trial details
Phase: Phase 2Age: 1-18Biological sex: AllType: InterventionalSponsor: Murdoch Childrens Research InstituteUpdated: Apr 8, 2026Locations: 7
Eligibility criteria

Immunocompromised patients including transplant recipients (haematopoietic stem... [+5]

Current or prior CMV infection with documented genotypic resistance to GCV (UL97... [+8]